Ozempic's next move, Southwest's seating change, and Big Tech's troubles: Business news roundupPublishedApril 27, 2024
Ozempic threatens booze and cigs, an AI glossary, tech troubles, produce pesticides: The week's most popularByQuartz StaffPublishedApril 26, 2024
Apple, Amazon, Nvidia, and other Big Tech stocks could see their profit growth 'collapse,' UBS saysByBruce GilPublishedApril 22, 2024
AI is becoming a big deal for big banks. What the CEOs of JPMorgan, Goldman Sachs and more are sayingByRocio FabbroPublishedApril 22, 2024
Goldman Sachs's CEO says the economic recovery isn't as sturdy as it looksByMelvin BackmanPublishedFebruary 27, 2024
Pickleball is expected to cost more than $350 million in medical injuries in the US this yearByJulia MalleckPublishedJune 27, 2023
UBS admitted it couldn't do full due diligence on Credit Suisse because of the rushed rescue mergerByDiego LasartePublishedMay 17, 2023
Credit Suisse reported its last-ever quarterly results—and it's still leaking moneyByAnanya BhattacharyaPublishedApril 24, 2023
Switzerland suspended a shareholder vote to merge UBS with Credit Suisse. Now it's investigating the dealByNate DiCamilloPublishedApril 3, 2023
Five major banks in France have been raided as part of a tax fraud probeByJulia MalleckPublishedMarch 28, 2023
Switzerland’s attractiveness as a business hub has been falling since 2013ByClarisa DiazPublishedMarch 27, 2023
